Literature DB >> 1996860

Experience in the surgical management of medullary thyroid carcinoma.

F J Lannigan1, J C Watkinson, S E Clarke, M N Maisey, O H Shaheen.   

Abstract

The management of 12 patients with medullary thyroid carcinoma is reviewed. All patients underwent total thyroidectomy. Local nodal and extracapsular spread was aggressively resected, followed by radiotherapy. No patient died from uncontrolled local disease. Prolonged survival after radical treatment is demonstrated even in the presence of distant metastases.

Entities:  

Mesh:

Year:  1991        PMID: 1996860      PMCID: PMC2499335     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  17 in total

1.  The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.

Authors:  S E Clarke; C Lazarus; R Mistry; M N Maisey
Journal:  Br J Radiol       Date:  1987-11       Impact factor: 3.039

2.  Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.

Authors:  M Ekblom; M Välimäki; R Pelkonen; R Jansson; A Sivula; K Franssila
Journal:  Q J Med       Date:  1987-11

3.  Calcitonin gene peptides: the diagnostic value of measurement in medullary thyroid carcinoma.

Authors:  S I Girgis; C Lynch; C J Hillyard; J C Stevenson; P A Hill; D W MacDonald; I MacIntyre
Journal:  Henry Ford Hosp Med J       Date:  1987

4.  The cytochemistry of the thyroid C cells and their relationship to calcitonin.

Authors:  A G Pearse
Journal:  Proc R Soc Lond B Biol Sci       Date:  1966-04-19

5.  Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma.

Authors:  J A Norton; L C Froome; R E Farrell; S A Wells
Journal:  Surg Clin North Am       Date:  1979-02       Impact factor: 2.741

6.  Multiple endocrine neoplasia type 2 syndromes: historical perspectives.

Authors:  J H Sipple
Journal:  Henry Ford Hosp Med J       Date:  1984

7.  Clinical value of calcitonin and carcinoembryonic antigen doubling times in medullary thyroid carcinoma.

Authors:  C E Jackson; R A Norum; G B Talpos; C S Feldkamp; A H Tashjian
Journal:  Henry Ford Hosp Med J       Date:  1987

8.  The surgical management of medullary thyroid carcinoma.

Authors:  C F Russell; J A Van Heerden; G W Sizemore; A J Edis; W F Taylor; W H ReMine; J A Carney
Journal:  Ann Surg       Date:  1983-01       Impact factor: 12.969

Review 9.  Advances in the diagnosis and treatment of medullary thyroid carcinoma.

Authors:  L M Brunt; S A Wells
Journal:  Surg Clin North Am       Date:  1987-04       Impact factor: 2.741

10.  Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.

Authors:  M F Saad; N G Ordonez; R K Rashid; J J Guido; C S Hill; R C Hickey; N A Samaan
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

View more
  1 in total

1.  Treatment of medullary carcinoma of the thyroid by laryngo-pharyngo-oesophagectomy--a case report.

Authors:  S Pender; D M Little; P Burke; P Broe
Journal:  Ir J Med Sci       Date:  1992-07       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.